Barclays Adjusts Elevance Health (ELV) PT to $393 While Maintaining Overweight Rating [Yahoo! Finance]
Elevance Health, Inc. (ELV)
Company Research
Source: Yahoo! Finance
price target on Elevance Health to $393 from $404 and kept an Overweight rating on the shares. On January 29, Guggenheim analyst Jason Cassorla also lowered the firm's price target on Elevance Health to $396 from $414 and maintained a Buy rating on recalibrated 2026 estimates following the company's Q4 2025 report. However, on the same day, Deutsche Bank raised the firm's price target on Elevance Health Inc. (NYSE:ELV) to $332 from $320 while maintaining a Hold rating on the shares. This decision was made as the firm suggested that the company's 2026 outlook may represent a floor. 15 States with the Best Healthcare in the US Furthermore, UBS also lowered the firm's price target on Elevance Health to $400 from $425 with a Buy rating. Elevance Health Inc. (NYSE:ELV), together with its subsidiaries, operates as a health benefits company in the US. It has four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. While we acknowledge the potential of E
Show less
Read more
Impact Snapshot
Event Time:
ELV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ELV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ELV alerts
High impacting Elevance Health, Inc. news events
Weekly update
A roundup of the hottest topics
ELV
News
- Elevance Health (NYSE:ELV) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=ELV&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen<MarketBeat
- How this generation of Olympic women erased the idea that motherhood is the end of a gold medal dream [CNN]CNN
- Cigna (CI) Reports Q4: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]Yahoo! Finance
- Elevance Health (NYSE:ELV) was downgraded by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from a "hold (c-)" rating to a "sell (d+)" rating.MarketBeat
- Elevance Health (NYSE:ELV) was downgraded by analysts at Royal Bank Of Canada from an "outperform" rating to a "sector perform" rating. They now have a $358.00 price target on the stock.MarketBeat
ELV
Earnings
- 1/28/26 - Beat
ELV
Sec Filings
- 2/6/26 - Form 10-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- ELV's page on the SEC website